Silvestrol antibody-drug conjugates and methods of use
US10639378B2 · kind B2 · utility
1Cited by
10References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2017 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | Jul 5, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates generally to a silvestrol molecule activated with a leaving group. The invention further relates generally to an antibody-drug conjugate comprising an antibody conjugated by a linker to one or more silvestrol drug moieties and methods of treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.